Cancer Clinical Trial -Pfizer-PF-07265028

PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors

Drug

ZL-1211

Phase

Phase I

Condition

Advanced Solid Tumors

Keywords

HPK1 inhibitor